Chris Viehbacher

Chris Viehbacher (born 1960) is a German-Canadian businessman.[1][2][3] He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.[1][2][3] Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.[4][5]

He joined Biogen as President and Chief Executive Officer and member of the Board of Directors in November 2022.[6]

  1. ^ a b Christopher Viehbacher – Forbes
  2. ^ a b "Sanofi - Christopher A. Viehbacher". Archived from the original on October 29, 2014. Retrieved October 29, 2014. Sanofi
  3. ^ a b Christopher A. Viehbacher | CEO Roundtable on Cancer
  4. ^ "Ex-Sanofi CEO talks about his new $2 billion investment fund". Retrieved 2017-09-13.
  5. ^ "Gurnet Point Capital nears deal to acquire drugmaker Innocoll: sources". Reuters. April 4, 2017. Retrieved 2017-09-13.
  6. ^ https://investors.biogen.com/news-releases/news-release-details/biogen-names-christopher-viehbacher-president-and-chief. {{cite web}}: Missing or empty |title= (help)